This clinical trial investigates the effects of Vitamin B6 supplementation on neural inhibition using electroencephalography (EEG), in relation to depression and anxiety symptoms in participants from the general population with a relatively high level of symptoms at baseline. Researchers will compare a placebo group to high-dose Vitamin B6 to test the hypothesis that Vitamin B6 moves the excitation/inhibition balance towards inhibition.
The primary question this trial aims to answer is: \- Compared to placebo, in people experiencing depression and anxiety symptoms, does high-dose Vitamin B6 supplementation change the excitation/inhibition balance towards inhibition as measured using electroencephalography (EEG)? Secondary research questions are: * Compared to placebo, does high-dose Vitamin B6 supplementation reduce symptoms of depression and anxiety? * Do individuals with lower Vitamin B6 levels at baseline, as measured in blood plasma, show a larger effect of high dose Vitamin B6 on the EEG measures or symptoms? * Compared to placebo, does high-dose Vitamin B6 intervention lead to an increase in hand grip strength? This is a possibility suggested to us by our prvious finding of reduced self reported 'postural disorder' by Vitamin B6 (Field et al., 2024), and by existing literature about the role of Vitamin B6 in muscle function.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
DOUBLE
Enrollment
44
100mg PLP in the form of a tablet, taken once a day for 1 week
Placebo supplement in the form of a capsule.
Harry Pitt Building
Reading, England, United Kingdom
RECRUITINGNeural inhibition measured using Electroencephalography
Time frame: From enrolment to the end of treatment 1 week later
Self-reported depression symptoms (Depression, Anxiety, and Stress questionnire, DASS)
Time frame: From enrolment to the end of treatment 1 week later
Self reported anxiety (Screen for Adult Anxiety Related Disorders, SCAARED)
Time frame: From enrolment to the end of treatment 1 week later
Hand grip strength
Time frame: From enrolment to the end of treatment 1 week later
Vitamin B6 status
We will quantify Vitamin B6 in capillary blood samples
Time frame: From enrolment to the end of treatment 1 week later
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.